Logo
O

Oncovalent Therapeutics

14 employees

Developer of Immuno oncology drugs intended to develop novel therapeutics to inhibit the human oncogene.

Basic info

Industry

biotechnology research

Sectors

Start Up
Biotechnology
Pharmaceutical
Cancer
Monoclonal Antibodies
Targeted Therapies
Oncology
Energetic
Entrepreneurial
Immuno Oncology
Therapeutics
Southern California
Clinical
Medicinal Chemistry
Early Stage
Drug Development
Molecular Biology
Young
Small Molecule
Experienced
Innovation
Pre-clinical

Date founded

2020

Funding rounds raised

O

Oncovalent Therapeutics raised undisclosed on September 9, 2020

Investors: Corner Ventures

FAQ